文献
J-GLOBAL ID:201702268617575739
整理番号:17A1165284
再発性卵巣癌におけるセジラニブと生活の質:ICON6第3相無作為化臨床試験【Powered by NICT】
Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial
著者 (11件):
Stark Dan P.
(St. James’s Institute of Oncology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom)
,
Cook Adrian
(Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom)
,
Brown Julia M.
(Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom)
,
Brundage Michael D.
(Queen’s University, Kingston, Ontario, Canada)
,
Embleton Andrew C.
(Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom)
,
Kaplan Richard S.
(Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom)
,
Raja Fharat A.
(Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom)
,
Swart Ann Marie W.
(Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom)
,
Velikova Galina
(St. James’s Institute of Oncology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom)
,
Qian Wendi
(Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom)
,
Ledermann Jonathan A.
(Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom)
資料名:
Cancer (Hoboken, N.J.)
(Cancer (Hoboken, N.J.))
巻:
123
号:
14
ページ:
2752-2761
発行年:
2017年
JST資料番号:
D0781B
ISSN:
0008-543X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)